1. Mathuranath PS, George A, Ranjith N, Justus S, Kumar MS, Menon R, et al. Incidence of Alzheimer’s disease in India: a 10 years follow-up study. Neurol India. 2012 Nov–Dec;60(6):625–30.
2. Viticchi G, Falsetti L, Buratti L, Sajeva G, Luzzi S, Bartolini M, et al. Framingham risk score and the risk of progression from mild cognitive impairment to dementia. J Alzheimers Dis. 2017;59(1):67–75.
3. Overton M, Pihlsgård M, Elmståhl S. Diagnostic stability of mild cognitive impairment, and predictors of reversion to normal cognitive functioning. Dement Geriatr Cogn Disord. 2019;48(5–6):317–29.
4. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol. 2000 Jun;57(6):808–13.
5. Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, et al. Mild cognitive impairment: ten years later. Arch Neurol. 2009 Dec;66(12):1447–55.